½ÃÀ庸°í¼­
»óǰÄÚµå
1384299

¼¼°è ½ÀÀ± »óó µå·¹½Ì ½ÃÀå - Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº° ¿¹Ãø(2023-2032³â)

Moist Wound Dressings Market - By Product, By Application, By End-use - Global Forecast, 2023-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÀÀ± »óó µå·¹½Ì ½ÃÀå ±Ô¸ð´Â °í±Þ »óó ÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿äÀÇ ±ÞÁõÀ¸·Î 2023-2032³âÀÇ CAGRÀÌ ¾à 5.4%°¡ µÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

½º¸¶Æ® ¼ÒÀç¿Í »ý¹°È°¼ºÈ­ÇÕ¹°ÀÇ ÅëÇÕ µîÀÇ ±â¼úÇõ½ÅÀÌ ÃÖÀûÀÇ »óóġÀ¯¸¦ ÃËÁøÇÏ´Â µå·¹½ÌÀçÀÇ È¿°ú¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.

World Population ProspectsÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2050³â±îÁö ¼¼°è 6¸í Áß 1¸íÀÌ 65¼¼ ÀÌ»óÀÇ ³ëÀÎÀÌ µÇ¾úÀ¸¸ç ÀÌ´Â ¼¼°è Àα¸ÀÇ 16%¿¡ ÇØ´çÇÕ´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡¿Í ¸¸¼º Áúȯ Áõ°¡´Â °í±Þ »óó °ü¸®ÀÇ Çʿ伺À» °­Á¶ÇÏ°í ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÕ´Ï´Ù.

½ÀÀ± »óó µå·¹½Ì ½ÃÀåÀº Á¦Ç°, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, Áö¿ª¿¡ µû¶ó ºÐ·ùµË´Ï´Ù.

ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå µå·¹½Ì ºÐ¾ß´Â 2023³âºÎÅÍ 2032³â±îÁö °­ÇÑ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ µå·¹½ÌÀç´Â »óó»ïÃâ¾×°ú »óÈ£ÀÛ¿ëÇÏ¿© °Ö»ó ¹°ÁúÀ» Çü¼ºÇϰí, ÀÚ°¡¿ëÇØ¼º ¹Ú¸®¸¦ µµ¿Í Ä¡À¯¸¦ Á¶ÀåÇÏ´Â ½ÀÀ±È¯°æÀ» Çü¼ºÇÕ´Ï´Ù. ÇÏÀ̵å·ÎÄÝ·ÎÀ̵åÁ¦ µå·¹½ÌÀç´Â À¯¿¬¼ºÀÌ ÀÖ¾î Àû¿ëÀÌ ¿ëÀÌÇϱ⠶§¹®¿¡ ÇコÄɾî Àü¹®°¡³ª ȯÀÚ¿¡°Ôµµ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. »óó Ä¡·á°¡ °è¼Ó ÁøÈ­ÇÏ´Â µ¿¾È, ÇÏÀ̵å·ÎÄÝ·ÎÀ̵åÁ¦ µå·¹½ÌÀç´Â Ä¡·á ȯ°æÀÇ º¯È­¿¡ À־ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù°í »ý°¢µË´Ï´Ù.

¿åâ ¿ëµµ´Â 2032³â±îÁö ½ÃÀå¿¡ °Å¾×ÀÇ ¼öÀÍÀ» °¡Á®¿Ã °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿åâÀÇ ¸¸¿¬Àº Á¾Á¾ ¿òÁ÷ÀÏ ¼ö ¾ø°Å³ª Àå±â ÀÔ¿ø°ú °ü·ÃÀÌ ÀÖÀ¸¸ç °í±Þ »óó Ä¡·á ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù. ½ÀÀ± »óó µå·¹½ÌÀº °¨¿° À§ÇèÀ» ÁÙÀ̰í À°¾Æ Á¶Á÷ Çü¼ºÀ» ÃËÁøÇÔÀ¸·Î½á ¿åâ °ü¸®¿¡ µµ¿òÀÌ µÇ´Â °ÍÀ¸·Î ÀÔÁõµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¿åâ °ü¸®¿¡ ÁßÁ¡À» µÐ Á¢±Ù¹ýÀº ½ÃÀå ÀüüÀÇ ¼ºÀå¿¡ ±â¿©ÇÕ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÀÀ± »óó µå·¹½Ì »ê¾÷Àº ±Þ¼ÓÇÑ °æÁ¦ ¹ßÀü°ú ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÁÖ¸ñÀÇ °íÁ¶·Î 2032³â±îÁö Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Áß±¹À̳ª Àεµ µî¿¡¼­´Â °í·ÉÈ­°¡ ±Þ¼ÓÈ÷ ÁøÇàµÇ°í ¸¸¼º ÁúȯÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ °í±Þ »óó ÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ½ÃÀå ÁøÃâ ±â¾÷Àº ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇöÀç »óŸ¦ Àü·«ÀûÀ¸·Î È®´ëÇϰí ÀÇ·á Á¾»çÀÚ¿Í È¯ÀÚÀÇ ÁøÈ­ÇÏ´Â Á¦Ç° ¼ö¿ä¿¡ ´ëÀÀÇÏ´Â °í±Þ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â À¯¸®ÇÑ ±âȸ¸¦ Ȱ¿ëÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÀÀ± »óó µå·¹½Ì »ê¾÷ ÀλçÀÌÆ®

  • COVID-19ÀÇ ¿µÇ⠺м®
  • »ýÅÂ°è ºÐ¼®
  • ±â¼ú »óȲ
  • ±ÔÁ¦ »óȲ
  • ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • È­»ó ¹ß»ý·ü Áõ°¡
      • ´ç´¢º´ À¯º´·ü Áõ°¡
      • ±Þ¼º ¹× ¸¸¼º »óó Áõ°¡
      • ÇコÄÉ¾î ¿¬±¸°³¹ß ÁøÀü
    • ¾÷°èÀÇ ÀáÀçÀû À§Çè ¹× °úÁ¦
      • ½ÀÀ± »óó µå·¹½ÌÀÇ ´ëüǰ
      • ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼Ò°³
    • Smith & Nephew
    • Medline Industries, Inc
    • Cardinal Health
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå ½ÀÀ± »óó µå·¹½Ì ½ÃÀå Ãß°è ¹× ¿¹Ãø : Á¦Ç°º°

  • ÁÖ¿ä µ¿Çâ : Á¦Ç°º°
  • Æû µå·¹½Ì
  • ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå µå·¹½Ì
  • Çʸ§ µå·¹½Ì
  • ¾ËÁö³×ÀÌÆ® µå·¹½Ì
  • ÇÏÀ̵å·Î°Ö µå·¹½Ì
  • ±âŸ

Á¦6Àå ½ÀÀ± »óó µå·¹½Ì ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¿ëµµº°

  • ÁÖ¿ä µ¿Çâ : ¿ëµµº°
  • ´ç´¢º´¼º ¹ß±Ë¾ç
  • ¿åâ
  • Á¤¸Æ¼º Çã¹÷Áö ±Ë¾ç
  • ¿Ü°úÀû ¹× ¿Ü»ó¼º »óó
  • ¿­»ó
  • ±âŸ

Á¦7Àå ½ÀÀ± »óó µå·¹½Ì ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä µ¿Çâ : ÃÖÁ¾ ¿ëµµº°
  • º´¿ø
  • Áø·á¼Ò
  • ±âŸ

Á¦8Àå ½ÀÀ± »óó µå·¹½Ì ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä µ¿Çâ : Áö¿ªº°
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ½ºÀ§½º
    • ³×´ú¶õµå
    • µ§¸¶Å©
    • Æú¶õµå
    • ½º¿þµ§
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ´ºÁú·£µå
    • ű¹
    • º£Æ®³²
    • Àεµ³×½Ã¾Æ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • Ä¥·¹
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ÅÍŰ

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Coloplast A/S
  • Medline Industries, Inc.
  • Smith & Nephew
  • Convatech Inc.
  • Systagenix
  • Derma Science, Inc.
  • Cardinal Health
  • Acelity
  • 3M
  • B. Braun Medical Inc.
JHS 23.12.04

Moist wound dressings market size is predicted to witness around 5.4% CAGR between 2023 and 2032 owing to the burgeoning demand for advanced wound care solutions. Technological innovations, such as the integration of smart materials and bioactive compounds, are enhancing the effectiveness of these dressings in promoting optimal wound healing.

According to the data from World Population Prospects, by 2050, one out of every six people in the world will be over 65 years age group, amounting to 16% of the world's population. An expanding geriatric population, coupled with the rising incidence of chronic diseases underscores the necessity for advanced wound care, spurring the market growth.

The moist wound dressing market is classified based on product, application, end-use, and region.

The hydrocolloid dressings segment is anticipated to record strong CAGR from 2023 to 2032. These dressings form a moist environment conducive to healing by interacting with wound exudate, forming a gel-like substance that aids in autolytic debridement. The flexibility and ease of application of hydrocolloid dressings make them a preferred choice for both healthcare professionals and patients. As wound care continues to evolve, hydrocolloid dressings are positioned to play a pivotal role in transforming the healing landscape.

The pressure ulcers application is expected to generate massive revenues for the market by 2032. The prevalence of pressure ulcers, often associated with immobility and extended hospital stays, has necessitated advanced wound care solutions. Moist wound dressings prove instrumental in managing pressure ulcers by reducing the risk of infection and promoting granulation tissue formation. This focused approach to pressure ulcer management is contributing to the overall market growth.

Asia Pacific moist wound dressings industry will grow significantly through 2032 due to rapid economic development and an increasing focus on healthcare infrastructure. The burgeoning aging population and a rise in chronic diseases in countries such as China and India are fueling the demand for advanced wound care solutions. Market players are strategically expanding their presence in the Asia Pacific, capitalizing on the lucrative opportunity of offering advanced solutions to meet the evolving product demand from medical practitioners & patients.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & workings
  • 1.3 Forecast calculations
  • 1.4 Data Sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Global moist wound dressings market 360 degree synopsis, 2018 - 2032
  • 2.2 Regional trends
  • 2.3 Product trends
  • 2.4 Application trends
  • 2.5 End-use trends

Chapter 3 Moist Wound Dressings Industry Insights

  • 3.1 COVID- 19 impact analysis
  • 3.2 Industry ecosystem analysis
  • 3.3 Technology landscape
  • 3.4 Regulatory landscape
  • 3.5 Industry impact forces
    • 3.5.1 Growth drivers
      • 3.5.1.1 Rising incidence of burn injuries
      • 3.5.1.2 Growing prevalence of diabetes
      • 3.5.1.3 Increasing cases of acute and chronic wounds
      • 3.5.1.4 Ongoing research and development (R&D) in the healthcare
    • 3.5.2 Industry pitfalls & challenges
      • 3.5.2.1 Alternatives to moist wound dressings
      • 3.5.2.2 Dearth of skilled professionals
  • 3.6 Growth potential analysis
    • 3.6.1 By product
    • 3.6.2 By application
    • 3.6.3 By end-use
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
    • 4.1.1 Smith & Nephew
    • 4.1.2 Medline Industries, Inc
    • 4.1.3 Cardinal Health
  • 4.2 Competitive analysis of major market players, 2022
  • 4.3 Competitive positioning matrix, 2022
  • 4.4 Strategic outlook matrix, 2022

Chapter 5 Moist Wound Dressings Market Estimates and Forecast, By Product (Revenue and Volume)

  • 5.1 Key trends, by product
  • 5.2 Foam dressings
  • 5.3 Hydrocolloid dressings
  • 5.4 Film dressings
  • 5.5 Alginate dressings
  • 5.6 Hydrogel dressings
  • 5.7 Others

Chapter 6 Moist Wound Dressings Market Estimates and Forecast, By Application (Revenue)

  • 6.1 Key trends, by application
  • 6.2 Diabetic foot ulcers
  • 6.3 Pressure ulcers
  • 6.4 Venous leg ulcers
  • 6.5 Surgical & traumatic wounds
  • 6.6 Burns
  • 6.7 Others

Chapter 7 Moist Wound Dressings Market Estimates and Forecast, By End-use (Revenue)

  • 7.1 Key trends, by end-use
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Others

Chapter 8 Moist Wound Dressings Market Estimates and Forecast, By Region (Revenue and Volume)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Switzerland
    • 8.3.7 The Netherlands
    • 8.3.8 Denmark
    • 8.3.9 Poland
    • 8.3.10 Sweden
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 New Zealand
    • 8.4.7 Thailand
    • 8.4.8 Vietnam
    • 8.4.9 Indonesia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Colombia
    • 8.5.5 Chile
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Turkey

Chapter 9 Company Profiles

  • 9.1 Coloplast A/S
  • 9.2 Medline Industries, Inc.
  • 9.3 Smith & Nephew
  • 9.4 Convatech Inc.
  • 9.5 Systagenix
  • 9.6 Derma Science, Inc.
  • 9.7 Cardinal Health
  • 9.8 Acelity
  • 9.9 3M
  • 9.10 B. Braun Medical Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦